View Older Stories View More Recent Stories

Aug 29, 2025 04:31PM Form N-PX RA CAPITAL MANAGEMENT, For: Jun 30
Aug 26, 2025 04:59PM Form SCHEDULE 13G/A Adagio Medical Holdings, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 26, 2025 09:00AM Ex-Amazon Robotics Leaders at Reframe Systems Raise $20M to Scale Microfactories to Tackle America’s Housing Crisis
Aug 22, 2025 12:00PM Invivyd closes $57.5 million public offering with full underwriter option
Aug 22, 2025 12:00PM Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Aug 20, 2025 04:41PM Form SCHEDULE 13G/A CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 18, 2025 05:52PM Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:14PM Form SCHEDULE 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:13PM Form SCHEDULE 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:12PM Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:10PM Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:08PM Form SCHEDULE 13G/A SERA PROGNOSTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:06PM Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:04PM Form SCHEDULE 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:03PM Form SCHEDULE 13G/A Protara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:02PM Form SCHEDULE 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 06:00PM Form SCHEDULE 13G/A Day One Biopharmaceutica Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 05:59PM Form SCHEDULE 13G/A CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 05:57PM Form SCHEDULE 13G/A Boundless Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 05:56PM Form SCHEDULE 13G/A Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 05:55PM Form SCHEDULE 13G/A Alector, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 05:53PM Form SCHEDULE 13G/A Adagio Medical Holdings, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2025 04:39PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 14, 2025 08:15AM Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
Aug 14, 2025 08:14AM Lilly signs up to $1.3 billion deal with Superluminal for obesity drugs
Aug 14, 2025 08:04AM Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity
Aug 11, 2025 04:43PM Form SCHEDULE 13D/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 8, 2025 08:05AM Assembly Biosciences prices $175 million equity financing with Gilead
Aug 8, 2025 08:05AM Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
Jul 30, 2025 08:00AM Be Bio Announces First Participant Dosed in BeCoMe-9 Trial of BE-101 in Hemophilia B
Jul 28, 2025 08:00PM Pahr Therapeutics Raises $14 Million Seed Financing to Pursue Innovative Treatments for Pulmonary Arterial Hypertension
Jul 25, 2025 05:01PM Form SCHEDULE 13G Contineum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 22, 2025 08:00AM RA Capital Management Announces $120 Million Planetary Health Fund
Jul 21, 2025 07:30AM SAB BIO Announces Oversubscribed $175 Million Private Placement
Jul 16, 2025 07:10AM Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda
Jul 1, 2025 08:00AM T-knife Therapeutics Appoints Christoph Broja to its Board of Directors
Jun 30, 2025 05:06PM Form SCHEDULE 13D/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 27, 2025 04:16PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 26, 2025 02:00AM PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
Jun 25, 2025 04:50PM Vor Biopharma (VOR) Announces $175 Million Private Placement
Jun 25, 2025 04:50PM Vor Bio Announces $175 Million Private Placement
Jun 12, 2025 01:27PM Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer
Jun 6, 2025 04:51PM Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 30, 2025 09:00AM Adela to Present Data Highlighting Ability of its Tissue-Agnostic Test for MRD Detection and Response Monitoring to Predict Progression and Identify Non-Responders to Immunotherapy in Solid Tumors at
May 29, 2025 07:00AM Navigator Medicines Announces First Participants Dosed in a Phase 1b Trial of NAV-240, a Potential Best-in-Class Anti-OX40L and Anti-TNFα Bispecific Antibody Therapeutic for Autoimmune Diseases
May 27, 2025 08:00AM New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth
May 19, 2025 05:46PM Form SCHEDULE 13D/A iTeos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 17, 2025 08:00AM Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia
May 15, 2025 05:00PM Form SCHEDULE 13G/A Kura Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:59PM Form SCHEDULE 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories